8-K: Karman Holdings Announces Strong Preliminary Q2 2025 Results Amidst Secondary Stock Offering
Preliminary Financial Results and Secondary Offering Announcement
Karman Holdings Inc. reported robust preliminary unaudited financial results for the second quarter of fiscal year 2025, showcasing significant growth in revenue and funded backlog, alongside the announcement of a secondary public offering by selling stockholders.
Summary
- Karman Holdings Inc. (Karman) announced a public underwritten offering of 20,000,000 shares of its common stock by certain selling stockholders, with an option for underwriters to purchase up to an additional 3,000,000 shares.
- Karman will not sell any shares in the offering and will not receive any proceeds from the sales.
- The company released preliminary unaudited financial results for the second quarter ended June 30, 2025, with estimated revenue between $114.5 million and $115.0 million, representing an increase of approximately 34.6% to 35.2% compared to $85.04 million in Q2 2024.
- Preliminary net income is expected to be between $6.17 million and $6.20 million, up from $4.60 million in Q2 2024.
- Funded backlog is estimated between $712.0 million and $715.0 million, an increase of approximately 34.8% to 35.4% compared to $528.01 million in Q2 2024.
- Adjusted EBITDA is projected to be between $34.85 million and $35.15 million, compared to $27.42 million in Q2 2024.
- Adjusted EBITDA margin is expected to be between 30.4% and 30.6%, a decrease from 32.2% in Q2 2024.
- Trive Capital, the company's largest stockholder prior to the offering (56.0% beneficial ownership), will effectuate a pro rata distribution-in-kind of its shares to its limited partners, contingent upon the consummation of the offering.
- New lock-up restrictions will apply to the distributed shares for Trive Capital senior principals (25% restricted for 360 days, 75% for 720 days), other Trive Capital personnel (360 days), and other distributees (360 days).
- Pre-IPO stockholders not participating in the offering may elect to have a portion of their shares released from the IPO lockup restriction (expiring February 11, 2026) no earlier than 90 days from the prospectus date, in exchange for new extended lock-up arrangements.
Sentiment
Score: 8
Explanation: The document reports strong preliminary financial results with significant growth in revenue and backlog, indicating robust business performance. While the company is not raising capital directly, the secondary offering by selling stockholders and the associated lock-up agreements provide clarity on major shareholder movements. The slight dip in Adjusted EBITDA margin is a minor concern but overall growth is very positive.
Positives
- Significant estimated revenue growth of approximately 34.6% to 35.2% for Q2 2025 compared to Q2 2024, reaching between $114.5 million and $115.0 million.
- Strong estimated increase in funded backlog by approximately 34.8% to 35.4% for Q2 2025 compared to Q2 2024, reaching between $712.0 million and $715.0 million.
- Estimated increase in gross profit for Q2 2025 to between $46.7 million and $47.0 million, up from $34.59 million in Q2 2024.
- Estimated increase in pretax income for Q2 2025 to between $8.31 million and $8.40 million, up from $4.92 million in Q2 2024.
- Estimated increase in net income for Q2 2025 to between $6.17 million and $6.20 million, up from $4.60 million in Q2 2024.
- Estimated increase in Adjusted EBITDA for Q2 2025 to between $34.85 million and $35.15 million, up from $27.42 million in Q2 2024.
Negatives
- Adjusted EBITDA margin is expected to decrease to between 30.4% and 30.6% for Q2 2025, down from 32.2% in Q2 2024.
- The company will not receive any proceeds from the secondary public offering, as shares are being sold by existing stockholders.
Risks
- Preliminary financial results are unaudited and subject to customary closing procedures and potential adjustments, meaning final results could differ.
- Forward-looking statements are inherently subject to known and unknown risks, uncertainties, and assumptions that could cause actual results to differ materially from those indicated.
- Risks and uncertainties are associated with the consummation of the public offering.
- General risks described in Karman's registration statement on Form S-1 and Annual Report on Form 10-K for the year ended December 31, 2024, and any subsequent SEC filings.
Future Outlook
Karman Holdings anticipates issuing final financial results for the second quarter of fiscal year 2025 on August 7, 2025, followed by a conference call and webcast. The preliminary results are forward-looking statements and are subject to change upon completion of customary closing procedures, though material differences are not expected. The company also expects to permit pre-IPO stockholders to elect for a portion of their shares to be released from the IPO lockup no earlier than 90 days from the prospectus date, in exchange for new extended lock-up arrangements.
Management Comments
- "We expect revenue to be between $114.50 million and $115.00 million, representing an estimated increase of approximately 34.6% and 35.2%, compared to revenue of $85.04 million for the three months ended June 30, 2024."
- "We expect funded backlog to be between $712.00 million and $715.00 million, representing an estimated increase of approximately 34.8% and 35.4%, compared to funded backlog of $528.01 million for the three months ended June 30, 2024."
- "Our final results remain subject to customary closing procedures or subsequent events, however we do not expect our final results to materially differ from the preliminary results shown below."
Industry Context
Karman Space & Defense operates as a leader in the rapid design, development, and production of critical, next-generation system solutions for the space and defense sectors, including launch vehicles, satellites, spacecraft, missile defense, hypersonics, and UAS. The reported strong growth in revenue and funded backlog suggests a robust demand within these specialized and high-growth segments of the aerospace and defense industry, aligning with global trends of increased investment in space exploration, satellite technology, and advanced defense systems. The secondary offering by selling stockholders, rather than the company itself, indicates a potential move by early investors to realize returns while the company continues its growth trajectory, without diluting existing shareholder value through new share issuance by the company.
Comparison to Industry Standards
- The document does not provide specific comparable companies, projects, or results to assess Karman's performance against global industry benchmarks.
- However, the reported revenue growth of 34.6% to 35.2% and funded backlog growth of 34.8% to 35.4% are indicative of strong performance within the specialized aerospace and defense sector, which often sees high growth rates driven by government contracts and technological advancements.
- The slight decrease in Adjusted EBITDA margin from 32.2% to an estimated 30.4%-30.6% could warrant further investigation in the context of industry peers, as it might suggest increased operational costs or investment in growth initiatives.
Related Party Transactions
- Trive Capital, the company's largest stockholder, will effectuate a pro rata distribution-in-kind of its shares to its limited partners for no consideration.
- This Trive LP Distribution is contingent upon the consummation of the public offering.
Stakeholder Impact
- Shareholders: Existing shareholders not participating in the offering may see increased liquidity in the stock due to the secondary offering and the eventual IPO lockup release. The offering by selling stockholders, rather than the company, means no direct dilution from new shares issued by the company. The strong preliminary financial results could positively impact investor confidence and share price.
- Trive Capital and its Limited Partners: Trive Capital will divest its beneficial ownership, and its limited partners will receive shares, subject to new lock-up restrictions, allowing them to realize value from their investment over time.
- Employees: No direct impact mentioned, but strong company performance generally benefits employees through stability and potential growth opportunities.
- Customers/Suppliers: Continued strong financial performance and growing backlog indicate stable operations and demand, which is positive for ongoing relationships.
Next Steps
- Finalize financial statements for the second quarter ended June 30, 2025.
- Issue final financial results for Q2 2025 after financial markets close on Thursday, August 7, 2025.
- Host a conference call and live audio webcast on August 7, 2025, at 1:30 p.m. Pacific Time to discuss Q2 2025 results.
- Consummate the public underwritten offering of 20,000,000 shares of common stock by selling stockholders.
- Effectuate the Trive LP Distribution concurrent with the consummation of the Offering.
- Potentially permit pre-IPO stockholders to elect for an IPO Lockup Release no earlier than 90 days from the prospectus date, subject to new lock-up arrangements.
Key Dates
| Date | Description |
|---|---|
| 2024-12-31 | End of fiscal year for which Annual Report on Form 10-K was filed. |
| 2025-02-11 | Expiration date of the IPO Lockup restriction under the operating agreement of Karman LLC. |
| 2025-06-30 | End of the second fiscal quarter for which preliminary unaudited financial results are reported. |
| 2025-07-21 | Date of the 8-K report and press releases announcing preliminary Q2 2025 results and the public offering. |
| 2025-08-07 | Company to issue final financial results for Q2 2025 after financial markets close. |
| 2025-08-07 | Management to host a conference call and live audio webcast at 1:30 p.m. Pacific Time to discuss Q2 2025 results. |
| 2025-08-07 | Audio replay of the conference call available from approximately 7:00 p.m. Pacific Time. |
| 2025-08-14 | Audio replay of the conference call available until 11:59 p.m. Pacific Time. |
Recommendation
holdKeywords
Karman Holdings, KRMN, Secondary Offering, Public Offering, SEC Filing, 8-K, Financial Results, Q2 2025, Revenue Growth, Funded Backlog, Adjusted EBITDA, Space & Defense, Aerospace, Defense Industry, Lock-up Agreement, Trive Capital, Stock Offering
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.